Intubation Clinical Trial
Official title:
A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting
Patients who are in the intensive care unit after surgery and require mechanical breathing support (intubation and ventilation) usually require sedation to avoid agitation and excessive stress responses. Short-acting sedatives such as midazolam and propofol are the drugs typically used for this. Propofol provides for fast sedation and fast recovery from sedation. Midazolam is slower to sedation and slower for recovery, but may provide some advantages over propofol, such as a lower incidence of hypotension (low blood pressure). This study will look at propofol compared to a product with fast sedation and recovery like that of propofol but with less of a chance for hypotension like with midazolam. Patients will be treated with the product for up to 8 hours and then will be monitored for 8 hours following treatment.
Patients who are intubated and ventilated and will require up to 8 hours of sedation in the
ICU are eligible for participation in this study. Patients will be randomized to receive 1
of 3 treatments. One treatment is standard of care, a propofol infusion. The other two
treatment arms are infusions of GPI 15715 (AQUAVAN), one with a bolus and one without.
Patients will be treated for up to 8 hours and monitored for eight hours post treatment. If
there are signs of agitation during the up to 8 hour treatment period, the infusion of the
sedative medicine will be increased according to protocol.
Blood samples will be obtained periodically during the course of the study for safety
evaluation and pharmacokinetic assessments. When the patient is ready for extubation or the
end of the 8 hour study period has been reached, the infusion of the sedative agent will be
discontinued and the patient will be monitored for 8 hours post treatment.
Guilford Pharmaceuticals was acquired by MGI PHARMA on October 3, 2005.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03277872 -
NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope
|
N/A | |
Suspended |
NCT04253795 -
Nonintubated Versus Intubated Anesthesia in Video-assisted Thoracic Surgery
|
N/A | |
Completed |
NCT02864017 -
Immuno Nutrition by L-citrulline for Critically Ill Patients
|
N/A | |
Completed |
NCT02900807 -
CT-scan Airways Mensuration - Correlation to External Measurements
|
||
Completed |
NCT01823328 -
Ketamine Versus Etomidate for Rapid Sequence Intubation
|
Phase 4 | |
Completed |
NCT02350933 -
Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation
|
N/A | |
Completed |
NCT01170455 -
Nasal Intubation Using the Blind Intubation Device
|
N/A | |
Completed |
NCT00980590 -
Airway Scope and Macintosh Laryngoscope for Tracheal Intubation in Patients Lying on the Ground
|
N/A | |
Completed |
NCT05515107 -
The Laryngoscopic View With C-MAC Videolaryngoscope Miller Blade Lifting the Epiglottis or the Vallecula in Children
|
N/A | |
Completed |
NCT06249659 -
Impact of Extubation Location After Surgery on Perioperative Times
|
||
Completed |
NCT03677505 -
KoMAC Videolaryngoscope for Double-lumen Intubation
|
N/A | |
Completed |
NCT03328182 -
Assessment of an Oral Endotracheal Subglottic Tube Holder
|
N/A | |
Recruiting |
NCT02277405 -
Pediatric Intubation During Resuscitation
|
N/A | |
Recruiting |
NCT02073786 -
Rigid Video Stylet Vs Conventional Lightwand Intubation
|
N/A | |
Recruiting |
NCT02277652 -
Endotracheal Intubation Devices
|
N/A | |
Completed |
NCT02277418 -
Venner a.p. Advance Video Laryngoscope
|
N/A | |
Completed |
NCT00956592 -
Clinical Evaluation of the Storz CMAC Laryngoscope
|
N/A | |
Completed |
NCT01003327 -
Comparison of the I-gel Laryngeal Mask and the Classic Laryngeal Mask in Patients With a BMI>25
|
Phase 4 | |
Completed |
NCT00783731 -
Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)
|
N/A | |
Recruiting |
NCT03887897 -
First Attempt Intubation Rate With Airtraq vs Macintosh Direct Laryngoscope
|
N/A |